Popular Articles

Stem Cell Therapeutics Corp. Announces Publication Of Phase I Stroke Data
Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) is pleased to announce the acceptance and publication of the paper entitled "Open labeled, uncontrolled pharmacokinetic study of single intramuscular hCG dose in healthy male volunteers" by the International Journal of Clinical Pharmacology and Therapeutics, Vol. 47, August 2009. This paper was authored by Drs. Alan Moore, President & CEO, Allen Davidoff, VP Product Development and Yan Yang, Clinical Research Associate, all of SCT; Dr. Michael D. Hill of Foothills Hospital at the University of Calgary, and Dr. Steven C. Cramer, from the University of California, Irvine.

India To Promote Drugs In Africa After Fake Chinese Drugs 'Made In India' Seized
India launched a project to promote its $10.7 billion pharmaceutical industry in Africa after fake drugs labeled "Made in India," but with actual origins in China were seized on the continent, IANS/Hindu reports. According to a commerce ministry statement, an effort to show ministers and senior officials in African nations "that the Indian generic industry is as safe as its patented versions and is available at much reasonable prices" is underway.
News of the day
Grants To Expand Work On Improving Women's Health And Understanding Gender Differences - Yale School of Medicine
Five Yale School of Medicine investigators have received of new Pilot Project Program grants from Women"s Health Research at Yale. They will study a variety of women"s health areas and gender differences that affect disease and behavior.
Diagnostics

Pioneering Research Into Healing Power Of Sugar

A pioneering University of Wolverhampton lecturer has won a ÷£25,000 grant to research the healing effect of sugar on cuts and wounds. Senior Lecturer Moses Murandu grew up in Zimbabwe and his father used granulated sugar to heal wounds and reduce pain when he was a child. But when he moved to the UK, he realised that sugar was not used for this purpose here. Moses, 43, carried out research into the effect of sugar on patients" wounds on the vascular ward at Selly Oak Hospital in Birmingham, funding the study himself for six months. He has now been awarded the prestigious Fondation Le Lous Scientific Research Innovation Award and ÷£25,000 to enable him to continue his innovative work. Sugar can be used on wounds such as bed sores, leg ulcers and even amputations. It works because bacteria needs water to grow, so applying sugar to a wound draws the water away and starves the bacteria of water. This prevents the bacteria from multiplying and they die. Moses found that a 25% sugar concentration ensures the microorganisms cannot survive. Mr Murandu, Senior Lecturer in Adult Nursing at the School of Health and Well Being, said: "Using granulated sugar in wounds has never been done in the UK before, although sugar paste has been used. When I was a child, my father used sugar or salt and I grew up without realising that something that works is not widely used. "While salt is painful, sugar is not and reduces the pain drastically. The patients we have tested it on in the pilot study have said that they never knew such a simple method could make such a difference to their quality of life. "I was happy for the patients who suffer from terrible and debilitating wounds with little hope of getting better, as this treatment can ease their pain." Jacqui Fletcher, Herve Le Lous Board Member, said: "Moses was awarded the prize not just because the quality of his proposal was excellent, but also because he challenged current thinking. In the UK we have a habit of saying "Ah yes we know in countries that can"t afford proper dressings they use other things, but when you are here you have the freedom and luxury of choosing a whole range of alternatives", but Moses didn"t think that way. He takes the view that he used sugar very effectively, therefore why wouldn"t it work equally well here? He should be commended for his tenacity in taking this project forward when many others would not even have started." Moses, from Edgbaston in Birmingham, was supported in his studies by Mr Malcolm Simms, consultant vascular surgeon at Selly Oak Hospital, who had worked in Uganda and witnessed the use of sugar there. Mr Murandu submitted an abstract to the Fondation Le Lous detailing his study and the benefits for patients. As well as ÷£25,000 over two years to further his research, Moses received a trophy and will also receive support from board member Carol Dealey, who is a Research Fellow at the University Hospital Birmingham NHS Foundation Trust and University of Birmingham. Originally from Zimbabwe, Moses Murandu studied midwifery in South Africa and also studied in Atlanta, Georgia, before coming to the UK to study a Masters at Birmingham University, supported by Professor Colette Clifford. As well as lecturing at the University of Wolverhampton, he is currently studying for a doctorate at Birmingham. University of Wolverhampton


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):